Evidence map›Paper›PMID 32805074›Full record

ArticleCurrent protocols in chemical biology2020

In Vitro Activity Assays to Quantitatively Assess the Endogenous Reversible Oxidation State of Protein Tyrosine Phosphatases in Cells.

Avinash D Londhe, Syed H M Rizvi, Benoit Boivin

Open access · greenAbstract read
In one paragraph

Article in Current protocols in chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Avinash D LondheDepartment of Nanobioscience, SUNY Polytechnic Institute, Albany, New York.
Syed H M RizviDepartment of Nanobioscience, SUNY Polytechnic Institute, Albany, New York.
Benoit BoivinDepartment of Nanobioscience, SUNY Polytechnic Institute, Albany, New York.
SUNY Polytechnic Institute · US

Funding

Role of the Phosphoprotein Phosphatase PTP1B in Cardiac HypertrophyR15HL138605 · NHLBI · SUNY POLYTECHNIC INSTITUTE · PI BOIVIN, BENOIT · 2017 to 2020
$896k
NHLBI NIH HHS R15 HL138605
6 · The paper itself

Abstract

The reversible oxidation of protein tyrosine phosphatases (PTPs) impairs their ability to dephosphorylate substrates in vivo. This transient inactivation of PTPs occurs as their conserved catalytic cysteine residue reacts with cellular oxidants thereby abolishing the ability of this reactive cysteine to attack the phosphate of the target substrate. Hence, in vivo, the inhibition of specific PTPs in response to regulated and localized rises in cellular oxidants enables phospho-dependent signaling. We present assays that measure the endogenous activity of specific PTPs that become transiently inactivated in cells exposed to growth factors. Here, we describe the methods and highlight the pitfalls to avoid post-lysis oxidation of PTPs in order to assess the inactivation and the reactivation of PTPs targeted by cellular oxidants in signal transduction. © 2020 Wiley Periodicals LLC. Basic Protocol 1: Cell transfection (optional) Support Protocol: Preparation of degassed lysis buffers Basic Protocol 2: Cellular extraction in anaerobic conditions Basic Protocol 3: Enrichment and activity assay of specific PTPs Alternate Protocol: Measurement of active PTPs via direct cysteinyl labeling.

Indexed as

HEK293 CellsHumansOxidation-ReductionProtein Tyrosine PhosphatasesProtein Tyrosine Phosphatasesactivity assaybiotin labelingpNPPprotein tyrosine phosphatasesredox signaling

Identifiers

PMID32805074
PMCPMC7493824
OpenAlexW3049333857

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.